Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{170856,
        author = {VAISHNAVI KIRAN CHIVTE and Dhanashree Kiran Chivte and Vaibhavi Sutar and Vasudha Sutar and Rohan Ingole},
        title = {HARNESSING THE POWER OF MICROBIOME RESEARCH IN DRUG DISCOVERY},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {752-760},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=170856},
        abstract = {The microbiome can affect sedate viability and poisonous quality, and microbiome impacts on medicate digestion system can be particular to person patients. To microbiome-drug intelligent as a key lost component in pharmacology and medicate improvement, It will start by characterizing the term “microbiome” and at that point briefly depicting the history of microbiome sedate digestion system investigate. There are the parallels between pharmacogenetics considers, which endeavor to evaluate the part human hereditary variety plays in medicate digestion system, and microbiome ponders of medicate digestion system; both must fight with a tremendous amount of uncharacterized and frequently unstructured hereditary differing qualities. Coordination ability from clinical pharmacology and fundamental microbiome investigate, in portion through particular subsidizing instruments, cross- disciplinary sessions at gatherings, and preparing pharmacologists in microbial sedate digestion system, will move us toward the extreme objective of tackling the microbiome to make strides medicate treatment.},
        keywords = {microbiome, microorganisms, drug metabolism, prebiotics, postbiotics, FMT},
        month = {December},
        }